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Tumor suppressor p53 is a sequence-specific DNA-binding
protein and its central DNA-binding domain (DBD) harbors
six hotspots (Arg175, Gly245, Arg248, Arg249, Arg273 and
Arg282) for human cancers. Here, the crystal structure of a
low-frequency hotspot mutant, p53DBD(R282Q), is reported
at 1.54 A˚ resolution together with the results of molecular-
dynamics simulations on the basis of the structure. In addition
to eliminating a salt bridge, the R282Q mutation has a
significant impact on the properties of two DNA-binding loops
(L1 and L3). The L1 loop is flexible in the wild type, but it is
not flexible in the mutant. The L3 loop of the wild type is not
flexible, whereas it assumes two conformations in the mutant.
Molecular-dynamics simulations indicated that both confor-
mations of the L3 loop are accessible under biological
conditions. It is predicted that the elimination of the salt
bridge and the inversion of the flexibility of L1 and L3 are
directly or indirectly responsible for deactivating the tumor
suppressor p53.
Received 26 December 2007
Accepted 30 January 2008
PDB Reference: p53 DNA-
binding domain, 2pcx,
r2pcxsf.
1. Introduction
Tumor suppressor p53 is a sequence-specific DNA-binding
protein (el-Deiry et al., 1992; Funk et al., 1992). As a tran-
scription factor, it plays an important role in response to
oncogenic stresses by regulating the expression of a range of
downstream genes to induce cell-cycle arrest and apoptosis
(Cho et al., 1994; Prives & Hall, 1999; Vogelstein et al., 2000;
Vousden & Lu, 2002; Oren, 2003). Therefore, p53 is crucial in
the prevention of cancer. The functional form of p53 is a
tetramer consisting of a dimer of dimers (Kitayner et al., 2006).
Each subunit contains four distinct domains: an N-terminal
activation domain (residues 1–93), a central DNA-binding
domain (DBD; residues 94–312; Fig. 1a), a tetramerization
domain (residues 324–355) and a C-terminal regulatory
domain (residues 360–393) (Wang et al., 1993; Cho et al., 1994;
Clore et al., 1995; Jeffrey et al., 1995; Weinberg et al., 2004). The
central DBD is also referred to as the ‘core’ domain. Although
the four domains can function autonomously, in vivo activity
of p53 requires the intact tetramer.
More than 50% of human cancers have missense mutations
in p53 which deactivate the tumor suppressor protein
(Hainaut & Hollstein, 2000; Olivier et al., 2002). Most of these
mutations map to the DBD of p53 (p53DBD), including the
six hotspots (Arg175, Gly245, Arg248, Arg249, Arg273 and
Arg282) found in human cancers (Hainaut & Hollstein, 2000).
On the basis of the crystal structure of human p53DBD in
complex with a consensus DNA (PDB code 1tsr), Arg248 and
Arg273 directly contact the DNA, while the others appear to
play a role in stabilizing the structure of the DNA-binding
surface of p53DBD (Cho et al., 1994). Arg248, which is located
in the L3 loop (Fig. 1a), makes a minor-groove contact with
the DNA. Arg273, which is located in the S10 strand, contacts
a backbone phosphate. Therefore, these two side chains are
not responsible for the sequence specificity of p53 towards
DNA. Recently, four crystal structures of sequence-specific
complexes of human p53DBD with different DNAs (PDB
codes 2ac0, 2ata, 2ahi and 2ady) have been reported,
providing the structural basis of sequence-specific DNA
recognition by p53 tetramers (Kitayner et al., 2006).
Four hotspots (Arg175, Gly245, Arg249 and Arg282) have
been predicted to play a role in maintaining the structure of
the DNA-binding surface of p53 (Cho et al., 1994) and struc-
tural data are available for R282W (PDB code 2j21; Joerger et
al., 2006), R249S (PDB code 2bio; Joerger et al., 2005) and
G245S (PDB code 2j1y; Joerger et al., 2006) mutants.
According to the 12th version R12 of the p53 mutation
database of the International Agency for Research on Cancer
(http://www-p53.iarc.fr), the frequencies of R282W, R249S
and R245S rank numbers 6, 7 and 8, respectively. Nonetheless,
the three mutant proteins were prepared on top of a quad-
ruple mutation, M133L/V203A/N239Y/
N268D, which introduces superstability to
the protein (Joerger et al., 2004). Therefore,
the impact of the hotspot mutations thus
observed may be biased by the quadruple
mutation. Compared with R282W, R282Q
has a 20 times lower frequency in human
cancer. We managed to prepare and crys-
tallize the mutant protein p53DBD(R282Q)
which contains the single-point mutation
only. Here, we present the 1.54 A˚ crystal
structure of human p53DBD(R282Q) and
the results of molecular-dynamics simula-
tions on the basis of the structure, revealing
the impact of this low-frequency hotspot
mutation on the structure of p53DBD.
2. Materials and methods
2.1. Mutagenesis, protein expression and
purification
The DNA sequence encoding the
N-terminal 6His-tagged p53 core domain
was initially optimized with the DNA-
WORKS program package (Hoover &
Lubkowski, 2002), which reverse-translated
the protein sequence by using the codon-
frequency table for Escherichia coli. A total
of 34 primers with optimized codons were
prepared and the DNAwas assembled using
the PCR technique. An NdeI and a BamHI
restriction site were created at the terminus
of the DNA to facilitate subsequent sub-
cloning. The synthesized DNA was sub-
cloned into the NdeI–BamHI sites of the
pET17b(+) vector. The R282Q gene muta-
tion was introduced using the QuikChange
site-directed mutagenesis kit (Stratagene).
Both sequences were verified by sequencing.
Expression was carried out at 293 K using
BL21 (DE3) cells and all purification steps
were performed at 277 K. Cells were resus-
pended and lysed in 50 mM sodium phos-
phate buffer pH 8 containing 300 mM NaCl,
20 mM imidazole, 1 mM leupeptin and
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Figure 1
The p53DBD(R282Q) mutant. (a) The amino-acid sequence of p53DBD(R282Q). The
mutation site is highlighted with a blue rectangle and the secondary structure is indicated
above the sequence: -strands are represented as yellow arrows, helices as red cylinders and
loops as black lines. (b) Ribbon diagram of the p53DBD(R282Q) structure, showing the
immunoglobulin-like -sandwich. The zinc ion is shown as a gray sphere and the Gln282
residue as a stick model. The L3 loop is disordered into two conformations. The color scheme is
the same as in (a). (c) Structure of disordered L3. Residues 239–246 (NSSCMGGM) are shown
as stick models (nitrogen in blue, oxygen in red, sulfur in orange and carbon in cyan and
magenta indicating the two conformations of L3) outlined with a composite annealed OMIT
map (2Fo  Fc, contoured at 1.0) in green.
10 mM -mercaptoethonal. The high-speed supernatant was
applied onto an Ni–NTA agarose column (Qiagen) and the
protein was sequentially eluted with 250 mM imidazole buffer.
Fractions were pooled and diluted with 50 mM sodium phos-
phate buffer pH 6.5. The sample was adjusted to 50 mM
sodium phosphate buffer pH 6.5 containing 100 mM NaCl,
83 mM imidazole and 5 mM dithiothreitol (DTT) before being
loaded onto an SP Sepharose High Performance column (GE
Healthcare). The protein was eluted with 50 mM sodium
phosphate buffer pH 7.0 containing 500 mM NaCl and 5 mM
DTT. A G25 spin column was used for buffer exchange and
the protein was concentrated to 15 mg ml1 in 50 mM bis-tris
buffer pH 6.9 containing 175 mM NaCl and 5 mM DTT for
crystallization experiments.
2.2. Crystallization and data collection
A Hydra II Plus One (Matrix Technologies Corporation)
crystallization robot system was employed to identify crys-
tallization conditions. Single crystals in space group P1 (unit-
cell parameters a = 34.9, b= 35.2, c= 41.6 A˚, = 111.8, = 94.9,
 = 112.4) were grown from Index crystallization screen
condition No. 80 (Hampton Research) at 292  1 K by mixing
0.4 ml protein solution and 0.2 ml reservoir solution containing
100 mM ammonium acetate and 25%(w/v) PEG 3350 in
100 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) buffer pH 7.5. Crystals of X-ray diffraction quality
grew in 2 d, reaching dimensions of 0.1 0.08 0.04 mm. The
crystal was soaked in mother liquor containing 15% ethylene
glycol and flash-frozen in liquid nitrogen for data collection.
X-ray diffraction data were collected with a MAR Research
image-plate scanner (MAR 345) mounted on a Rigaku
rotating-anode generator at 100 K maintained with an Oxford
Cryostream system. Data processing was carried out with
HKL-2000 (Otwinowski & Minor, 1997). Crystal data and
processing statistics are summarized in Table 1. Further data
processing was carried out with the CCP4 suite (Collaborative
Computational Project, Number 4, 1994) for crystal structure
determination.
2.3. Structure determination
The p53DBD(R282Q) structure was solved by molecular
replacement using AMoRe (Navaza, 1994). The search model
was chain A (DNA-free) of the wild-type p53DBD structure
(PDB code 1tsr). There was one molecule in the asymmetric
unit. Structural refinement was carried out with CNS (Bru¨nger
et al., 1998) and SHELXL97 (Sheldrick, 2008). During the
refinement, the 2Fo  Fc and Fo  Fc electron-density maps
were regularly calculated for inspection and improvement of
the model. Water molecules were added to the structure using
the water-picking routine embedded in CNS at the later stages
of the refinement and were verified with annealed OMIT
maps. The L3 loop (residues 239–246; Fig. 1c) and residues
106, 116, 122, 217, 277, 283 and 290 were disordered and
refined as two conformations with equal probabilities. The
refinement statistics are summarized in Table 1. PROCHECK
(Laskowski et al., 1993) was used to check the stereochemistry
of the structure and PyMOL (DeLano Scientific LLC) was
used to generate the illustrations.
2.4. Molecular-dynamics simulations
Molecular-dynamics (MD) simulations were performed on
each of the two L3 conformations of the p53DBD(R282Q)
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Table 1
X-ray diffraction data and refinement statistics.
Values in parentheses are for the highest resolution shell.
X-ray data
Resolution (A˚) 30.0–1.54 (1.60–1.54)
Measured reflections 101712
Unique reflections 21850
Completeness (%) 88.0 (49.7)
Multiplicity 4.7 (2.6)
Rmerge† 0.043 (0.402)
I/(I) 33.9 (1.9)
Refinement
No. of atoms (non-H)
Protein 1623
Water 252
Zn 1
R factor‡ 19.6
Rfree‡ 23.6
R.m.s.d.
Bond distances (A˚) 0.004
Bond angles () 1.3
Average B factors (A˚2)
Protein 26.8
Water 42.9
Zinc 21.8
Ramachandran statistics (%)
Most favored ’/ values 90.3
Disallowed ’/ values 0.0
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ R factor and Rfree =PjFobsj  jFcalcj

=
P jFobsj, where Rfree was calculated over 5% of amplitudes chosen
at random and not used in the refinement.
Figure 2
Main-chain r.m.s.d. distributions of L3 (residues 237–250) over simulation
time. Distributions for five overlapping sampling windows are shown: the
black line is for snapshots in the range 10–30 ns, the red line 15–35 ns, the
green line 20–40 ns, the blue line 25–45 ns and the yellow line 30–50 ns.
All ten independent trajectories were used. Avery good convergence can
be observed when comparing sampled structures from 20 to 50 ns,
corresponding to 200 to 500 ns simulation time from ten independent
trajectories.
structure. Explicit TIP3P solvents were added to fully solvate
the proteins in truncated octahedral periodic boxes in the
LEAP module of Amber 8 (Case et al., 2004). The minimum
distance from the protein surface to the box boundary was set
to be 8.0 A˚. Counter-ions were added to neutralize the
proteins. The particle mesh Ewald method (Darden et al.,
1993) with default parameters was used in Amber 8 (Case et
al., 2004) to treat long-range electrostatics and van der Waals
interactions. A revised parm99 force field was used for intra-
molecular interactions (Wang et al., 2000; Lwin & Luo, 2006).
MD simulations were started after a brief steepest-descent
minimization of 500 steps to relax any possible clashes.
SHAKE (Ryckaert et al., 1997) was turned
on for bonds containing H atoms, so that a
time step of 2 fs can be used in the leapfrog
(Hockney & Eastwood, 1981) numerical
integrator for MD simulations. Constant
temperature (300 K) and constant pressure
(105 Pa) were maintained using Berendsen’s
methods (Berendsen et al., 1984). To study
the conformational distribution of the loop,
a cumulative 500 ns was run (ten indepen-
dent trajectories) for the two starting
conformations.
2.5. Analysis of MD simulation data
Main-chain root-mean-square deviation
(r.m.s.d.) based clustering analysis was used
to reduce the enormous amount of simula-
tion data to a manageable amount. The
r.m.s.d. was calculated for the loop region
only (residues 237–250) with respect to the
mean structure over the data-collection
portion (10–50 ns) in all ten independent
trajectories. The r.m.s.d. distribution natu-
rally divides the sampled snapshots into two
clusters: cluster 1 contains the snapshots
with r.m.s.d.  4.08 A˚ and cluster 2 contains
the snapshots with r.m.s.d. > 4.08 A˚ (Fig. 2).
The sampling convergence was monitored
by analyzing the change in r.m.s.d. distribu-
tion over simulation time as shown in Fig. 2.
A total of five overlapping windows were
used from 10 to 50 ns, resulting in five
r.m.s.d. distribution curves. Each distribu-
tion curve was generated from 200 ns snap-
shots (one per 10 ps in ten independent
trajectories) during every 20 ns window. The
final converged populations in clusters 1 and
2 were obtained after fitting the time-
dependent population data (over the five
overlapping windows) to single-exponential
decay curves (R2 = 0.995) and the converged
population is 89.7% and 10.3% for clusters 1
and 2, respectively.
3. Results and discussion
3.1. Overall structure
We determined the crystal structure of
p53DBD(R282Q) at 1.54 A˚ resolution
(Fig. 1). The final model comprises residues
research papers
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Figure 3
Comparison of the p53DBD(R282Q) structure with wild-type structures. (a) The C trace of
p53DBD(R282Q) is shown in magenta and is superimposed with DNA-free (PDB code 1tsr;
chain A, yellow) and DNA-bound (chain B, cyan; chain C, blue) wild-type protein. The four
indicated regions (L1, L2, L3 and S7/S8) are significantly different. (b) C superposition of
p53DBD(R282Q) (in magenta) with the DNA-bound wild-type structure (in cyan). Protein is
shown as ribbons, DNA as sticks and zinc as a sphere. (c) Close-up view of the protein–DNA
interface in proximity to the L1 and L3 loops. Side chains are shown for residues Gln282 (the
mutation site), Ser116 (in L1), and Lys120 and Ser241 (DNA binding). A hydrogen bond
between Gln282 and Ser116 is indicated by a dashed line.
94–292, consisting of two antiparallel -sheets of four (S1, S3,
S8 and S5) and five (S10, S9, S4, S7 and S6) strands in a
-sandwich topology, similar to previously reported p53DBD
structures (Fig. 3a). The -sandwich provides the basic scaf-
fold for a loop–sheet–helix motif (L1 and H2); the L2 and L3
loops, two large loops tethered by a zinc ion,
interact with the major and minor groove of
the bound DNA, respectively (Fig. 3b). The
zinc ion is tetrahedrally coordinated by
Cys176 and His179 from L2 and Cys238 and
Cys242 from L3. Two conformations of L3
have been observed with equal probability
(Fig. 1c).
The crystal structure of wild-type
p53DBD in complex with DNA (PDB code
1tsr) contains three chains. Chain A is not
associated with DNA. Chain B is a DNA-
bound form and the binding is specific for a
consensus DNA sequence. Chain C is also a
DNA-bound form, but the binding is non-
specific (Cho et al., 1994). When the
p53DBD(R282Q) structure is superimposed
with the wild type (PDB code 1tsr), the
r.m.s.d. for all C atoms is 0.57 A˚ for chain
A, 0.58 A˚ for chain B and 0.59 A˚ for chain C
and the most noticeable deviations are
observed in the L1, L2 and L3 loops and a
turn between the S7 and S8 strands (Fig. 3a).
3.2. The L1 loop in p53DBD(R282Q) is not
as flexible as in the wild type
Several previous comparative analyses of
available p53DBD structures have shown
that the L1 and L2 loops and the S7/S8 turn
are inherently flexible (Ho et al., 2006;
Kitayner et al., 2006; Wang et al., 2007).
However, of the three structural elements
only L1 is in direct contact with the bound
DNA (Fig. 3b). Thus, the flexibility of L1
may be important for the DNA-binding
activity of p53 because residue Lys120,
which is located at the apex of L1, is
involved in the sequence-specific central
recognition of DNA (Cho et al., 1994;
Kitayner et al., 2006). In the complex of
wild-type p53 with DNA, Lys120 N makes
hydrogen bonds with either one (Cho et al.,
1994) or two nucleotide bases (Kitayner et
al., 2006) in the major groove depending on
the sequence of the bound DNA. However,
as shown in Fig. 3(c), the Lys120 position in
the DNA-free form is not compatible with
DNA binding. Therefore, the flexibility of
L1 is important for the DNA-binding
activity of p53.
Although the L1 loop in the p53DBD(R282Q) structure
resembles that previously found in the DNA-free wild-type
structure (Fig. 3a), its conformation near Ser116 is significantly
distorted (Fig. 3c). The side chain of Gln282 forms three
hydrogen bonds with nearby residues, including one between
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Figure 4
Structural changes around the mutation site in p53DBD(R282Q). (a) The structure of the
mutation site and nearby residues is shown as a stick model outlined with a composite
annealed OMIT map (2Fo  Fc, contoured at 1.0, green). Hydrogen bonds are indicated by
dashed lines. (b) The hydrogen-bond network of Gln282 in the mutant structure (magenta) is
compared with that of Arg282 in the wild-type DNA-free structure (green). (c) Residues 114–
117 in p53DBD(R282Q) (magenta) are superimposed with those in the wild-type DNA-free
structure (green), showing the flipped peptide bond between Leu114 and His115 in the mutant
structure.
its N"2 atom and the backbone carbonyl of Ser116 (Fig. 4a). In
the wild type, however, Arg282 does not interact with Ser116
or any other residues in L1 (Fig. 4b). Thus, the L1 loop in the
mutant appears to be pulled over toward the hydrophobic
core of the -sandwich (Fig. 3c). The C atom of Ser116 is
displaced by4 A˚ compared with that in the wild type and the
peptide bond between residues Leu114 and His115 is flipped
(Fig. 4c). The flipped peptide bond is stabilized by two more
hydrogen bonds: one between His115 and Cys124 and the
other between His115 and Gly117 (not shown). In the wild
type, however, His115 does not form any hydrogen bonds to
adjacent residues. Therefore, the L1 loop in the
p53DBD(R282Q) structure has a stabilized distorted DNA-
free conformation and is not suitable for DNA binding.
3.3. The L3 loop in p53DBD(R282Q) is not as stable as in the
wild type
Unlike the three inherently flexible motifs (L1, L2 and S7/
S8), the L3 loop exhibits no significant conformational varia-
tions among previously reported structures, either DNA-free
or DNA-bound, as long as the mutation site is not located in
the loop (Ho et al., 2006; Kitayner et al., 2006; Wang et al.,
2007). The loop contains the Zn2+-binding site and makes
direct interactions with the minor groove of consensus DNA
(Fig. 3b). Thus, the stability (conformational integrity) of L3
may be important for the DNA-binding activity of p53.
However, in the p53DBD(R282Q) structure two L3 confor-
mations were observed with equal probability (Fig. 1c). One
conformation is the same as that previously reported, while
the other is new (Fig. 3a). Between the two conformations, the
C atom of Ser241 is shifted by 2.8 A˚ (Fig. 1c). In the
previously observed conformation, Ser241 O makes one
hydrogen bond to the phosphodiester backbone in the minor
groove. In the new conformation, however, the position of
Ser241 is not compatible with DNA binding (Fig. 3c). Inter-
estingly, however, the position of the zinc ion is virtually
identical in the two conformations. Although the mutation site
(residue 282) is distant from L3 (Fig. 3c), the impact of the
mutation may be propagated through the structural elements
in between, especially the H2 helix in which residue 282 is
located.
The flexibility of L3 was also shown by our MD simulations.
The mean structures for both simulation clusters are
compared with the two conformations observed in the
p53DBD(R282Q) structure. R.m.s.d. values among the two
mean structures from the MD simulations and the two
conformations of the crystal structure were computed for
residues 237–250 and for residues 239–246, respectively
(Fig. 5). It was found that the cluster 1 mean structure (sa) is
similar to both conformations of the crystal structure (xa and
xb), but that the cluster 2 mean structure (sb) is very different.
All four main-chain structures are shown in Fig. 6(a). Our
explicit water MD simulations of a protein monomer yields a
research papers
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Figure 5
Comparison of crystal structures and MD simulation structures. (a)
Pairwise main-chain r.m.s.d.s (A˚) for L3 residues 237–250 among the two
X-ray (xa and xb) and two mean simulation (sa and sb) structures. (b)
Pairwise main-chain r.m.s.d.s (A˚) for residues 239–246 among the two
X-ray (xa and xb) and two simulation (sa and sb) structures.
Figure 6
Dynamics simulations. (a) Main-chain structures for L3 residues 237–250.
Two X-ray structures are shown in blue (xa) and red (xb) and two mean
simulation structures are shown in yellow (sa) and gray (sb). The
Zn-binding site (residue 238) is indicated by spheres. (b) Main-chain root-
mean-square fluctuations (r.m.s.f.) for L3 residues 237–250 in cluster 1 are
shown in black and those in cluster 2 in blue.
predominant structural cluster (sa; 89.7%) that is close to the
two conformations in the crystal structure (xa and xb).
Furthermore, the main-chain root-mean-squared fluctuation
(Fig. 6b) shows that the r.m.s.d. difference between sa and xa/
xb is well within the fluctuation of cluster 1. This indicates that
both xa and xb are accessible to p53(R282Q) under biological
conditions. What is more interesting is that L3 is observed to
be highly flexible, with 10.3% of snapshots occupying a minor
structural cluster (sb) very different from the two conforma-
tions observed in the crystal structure. Therefore, the L3 loop
in the p53DBD(R282Q) mutant is disordered, with at least
50% of the population not being suitable for DNA binding.
3.4. The R282Q mutation eliminates an important salt bridge
In the wild-type p53DBD structure, the aliphatic portion of
the Arg282 side chain makes van der Waals contacts with
Phe134, Thr125 and Ser127 and its guanidinium group forms
hydrogen bonds to Thr118, Tyr126, Ser127 and Glu286 (Cho et
al., 1994). In p53DBD(R282Q), however, these interactions
are perturbed (Fig. 4b), among which the loss of the salt bridge
between the side chains of Arg282 and Glu286 is perhaps the
most significant because salt bridges contribute directly to the
stability of proteins. Previously, it has been estimated that the
R282Q mutation reduces the stability of p53DBD by
8.8 kJ mol1 at 283 K (Butler & Loh, 2003).
4. Conclusions
In addition to eliminating a salt bridge, the low-frequency
hotspot mutation R282Q has a significant impact on the
property of two DNA-binding loops (L1 and L3). The L1 loop
is flexible in the wild type, but it is not flexible in the mutant.
The L3 loop of the wild type is not flexible, whereas it assumes
two conformations in the mutant. Molecular-dynamics simu-
lations indicated that both conformations of the L3 loop are
accessible under biological conditions.
This research was supported by NIH grant GM069620 (to
RL) and the Intramural Research Program of the NIH,
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